Hospital Pharmacy - September 2017 - 569

569

McDaniel et al
This study included a single focus group meeting with 3
ICU team members participating. It may not have been a large
enough sample to gather substantial positive or negative
impacts on the ICU team members' satisfaction with the additional pharmacist. A focus group to gather ICU team members'
baseline experiences was not performed and could have been
useful for comparing with the poststudy experiences.

Conclusion
During this study, the complexity of the pharmacists' interventions was maintained, with the majority of interventions being
moderate complexity. Desirable and optimal clinical activities
performed per day nearly doubled and more than tripled, respectively. Most of the desirable and optimal clinical activities performed related to prospective chart review, patient rounding, and
educational activities. ICU team members reported mostly
favorable experiences with the additional pharmacist coverage.
This study showed that additional critical care pharmacist coverage positively impacted the level of clinical activities performed
by the pharmacists and the ICU team members' satisfaction.
Authors' note
Joshua McDaniel was a PGY1 pharmacy resident at the time
of the research and submission of the article.
Declaration of Conflicting Interests
The author(s) declared no potential conflicts of interest with respect
to the research, authorship, and/or publication of this article.

Funding
The author(s) received no financial support for the research, authorship, and/or publication of this article.

References
1. Papadopoulos J, Rebuck JA, Lober C, et al. The critical
care pharmacist: an essential intensive care practitioner.
Pharmacotherapy. 2002;22(11):1484-1488.
2. Horn E, Jacobi J. The critical care clinical pharmacist: evolution
of an essential team member. Crit Care Med. 2006;34(Suppl
3):S46-S51.
3. Erstad BL. A primer on critical care pharmacy services. Ann
Pharmacother. 2008;42:1871-1881.
4. Erstad BL, Hass CE, O'Keeffe T, et al. Interdisciplinary
patient care in the intensive care unit: focus on the pharmacist.
Pharmacotherapy. 2011;31(2):128-137.
5. Chant C, Dewhurst NF, Friedrich JO. Do we need a pharmacist
in the ICU? Intensive Care Med. 2015;41:1314-1320.
6. Kane SL, Weber RJ, Dasta JF. The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Med.
2003;29:691-698.
7. Rudis MI, Brandl KM. Position paper on critical care
pharmacy services. Society of Critical Care Medicine
and American College of Clinical Pharmacy task force on
critical care pharmacy services. Crit Care Med. 2000;28:
3746-3750.
8. Sanchez D, Feyerharm J, Krick J, et al. Charging for inpatient
medication therapy management. Pharmacy Purchasing and
Products Mag. 2014;11:30-34.
9. MacLaren R, Devlin JW, Martin SJ, et al. Critical care pharmacy services in United States hospitals. Ann Pharmacother.
2006;40:612-618.
10. The Society of Critical Care Medicine and the ICU Liberation
Campaign. ABCDEF Bundle Improvement Collaborative.
ICU Liberation Campaign. http://www.iculiberation.org/
About/collaborative/Pages/default.aspx. Accessed July 19,
2016.
11. The Society of Critical Care Medicine and the ICU Liberation
Campaign. ABCDEF Bundle. ICU Liberation Campaign.
http://www.iculiberation.org/Bundles/Pages/default.aspx.
Accessed May 18, 2016.

http://www.iculiberation.org/About/collaborative/Pages/default.aspx http://www.iculiberation.org/About/collaborative/Pages/default.aspx http://www.iculiberation.org/Bundles/Pages/default.aspx

Table of Contents for the Digital Edition of Hospital Pharmacy - September 2017